A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression

被引:17
作者
Llado, A. [1 ]
Fortea, J. [1 ]
Ojea, T. [2 ]
Bosch, B. [1 ]
Sanz, P. [3 ]
Valls-Sole, J. [4 ]
Clarimon, J. [5 ]
Molinuevo, J. L. [1 ]
Sanchez-Valle, R. [1 ]
机构
[1] Hosp Clin Barcelona, Alzheimers Dis & Other Cognit Disorders Unit, IDIBAPS, E-08036 Barcelona, Spain
[2] Hosp Reg Univ Carlos Haya, Inst Neurociencias, Unidad Memoria, Malaga, Spain
[3] Hosp Mataro, Mataro, Spain
[4] Hosp Clin Barcelona, Serv Neurol, EMG Unit, E-08036 Barcelona, Spain
[5] CIBERNED, Hosp Santa Creu & St Pau, Neurogenet Unit, Neurol Dept,Alzheimers Lab, Barcelona, Spain
关键词
Alzheimer disease; familial dementia; missense mutation; presenilin; PRESENILIN-1;
D O I
10.1111/j.1468-1331.2010.02949.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To describe a novel mutation (K239N) in the PSEN1 associated with familial Alzheimer's disease (AD). Methods and results: The proband was a man who developed cognitive decline with marked behavioural abnormalities at age 57. At age 70, he was admitted into a psychiatric facility because of aggressiveness and a suicide attempt. Family history was consistent with autosomal dominant AD. One of the two other family members studied presented also with prominent behavioural symptoms at age 42 and has also been forced into a psychiatric facility because of aggressiveness at age 56. The remainder patient has presented a prototypical AD, but starting at age 71. Direct sequencing of PSEN1 in the three living affected members disclosed a heterozygous G to C transition in exon 7 of PSEN1 leading to the K239N mutation. Conclusion: The K239N mutation is associated with autosomal dominant AD with a wide range of age of onset and incomplete penetrance at the age of 65, prominent behavioural features and slow progression.
引用
收藏
页码:994 / 996
页数:3
相关论文
共 8 条
[1]  
[Anonymous], ALZHEIMER DIS FRONTO
[2]   Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population based study of presenile Alzheimer disease [J].
Cruts, M ;
van Duijn, CM ;
Backhovens, H ;
Van den Broeck, M ;
Wehnert, A ;
Serneels, S ;
Sherrington, R ;
Hutton, M ;
Hardy, J ;
St George-Hyslop, PH ;
Hofman, A ;
Van Broeckhoven, C .
HUMAN MOLECULAR GENETICS, 1998, 7 (01) :43-51
[3]  
GUERREIRO RJ, 2008, NEUROBIOL AGING 0728
[4]  
Houlden H, 2000, ANN NEUROL, V48, P806, DOI 10.1002/1531-8249(200011)48:5<806::AID-ANA18>3.0.CO
[5]  
2-F
[6]   Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40 [J].
Kumar-Singh, Samir ;
Theuns, Jessie ;
Van Broeck, Bianca ;
Pirici, Daniel ;
Vennekens, Krist'l ;
Corsmit, Ellen ;
Cruts, Marc ;
Dermaut, Bart ;
Wang, Rong ;
Van Broeckhoven, Christine .
HUMAN MUTATION, 2006, 27 (07) :686-695
[7]   Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene [J].
Larner, AJ ;
Doran, M .
JOURNAL OF NEUROLOGY, 2006, 253 (02) :139-158
[8]  
Molinuevo Jose L, 2005, Am J Alzheimers Dis Other Demen, V20, P233, DOI 10.1177/153331750502000408